Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina

scientific article published on May 2005

Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/HRT.2004.036509
P932PMC publication ID1768899
P698PubMed publication ID15831660
P5875ResearchGate publication ID7904821

P2093author name stringF Crea
M Lombardi
L M Biasucci
G Di Giannuario
G Liuzzo
M Piro
P2860cites workUsefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart diseaseQ28195766
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosisQ32054951
Angiotensin receptors: distribution, signalling and functionQ33941829
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery diseaseQ43796478
Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable AnginaQ58230288
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)670-671
P577publication date2005-05-01
P1433published inHeartQ856338
P1476titleIrbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina
P478volume91